CP
Crinetics Pharmaceuticals, Inc. - Common Stock
CRNX
Close · 02/09/2026
84.95
1D
0.00%52-week range
32.3 – 85.01
Volume
0.00
Price history
CRNX
04/08/2026 to 02/09/2026
O 84.95 H 84.95 L 84.95
1W+0.13%
1M+1.30%
3M+156.72%
6M+115.01%
1Y+155.11%
3Y+398.83%
5Y+283.35%
MAX+350.66%
Fundamentals
as of 02/09/2026- Market cap
- $9.01B
- Shares out
- 106.07M
- P/E (forward)
- -20.63
- EPS (trailing)
- -4.73
- Beta
- 0.09
- Profit margin
- -1189.88%
- P/B
- 7.56
- Return on equity
- -42.08%
SEC financial statements
32 quarterly and 10 annual periods through 30/06/2026.
Details
- Ticker
- CRNX
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 02/09/2026.
Tracked by Congress
2 filers · 1 on watchlist · 4 buys · 2 sells · D: 6
- 30/07/2026Gilbert CisnerosSellCrinetics Pharmaceuticals, Inc. - Common Stock$15,001–$50,000
- 03/03/2026Gilbert CisnerosBuyCrinetics Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 17/04/2025Gilbert CisnerosBuyCrinetics Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 19/03/2025Josh GottheimerWSellCrinetics Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 29/01/2025Gilbert CisnerosBuyCrinetics Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 25/09/2024Josh GottheimerWBuyCrinetics Pharmaceuticals, Inc. - Common Stock$1,001–$15,000